Category: PMCPA Case of the Week

Cases selected for the AskAnzal weekly PMCPA insight newsletter

8 Mar 2026

AUTH/2703/3/14: Anonymous consultant haematologist v Chugai (Granocyte) β€” no breach

Anonymous haematologist alleged a Chugai rep used inaccurate/misleading information about Granocyte, including extrapolating healthy donor data to neutropenia…

8 Mar 2026

AUTH/2730/9/14: Anonymous health professional v Merck Serono β€” ESHRE congress hospitality and sponsorship (No breach)

Anonymous complaint alleged late-night drinking with HCPs and β€œprescribing-linked” sponsorship at ESHRE 2014. Panel raised concerns about optics…

8 Mar 2026

AUTH/2811/12/15: Anonymous v Daiichi-Sankyo – emailed photo booth images ruled a prohibited gift from a promotional stand

At ESC 2015, Daiichi-Sankyo’s stand included a photo booth that emailed delegates their photos. PMCPA ruled the emailed…

8 Mar 2026

AUTH/2936/2/17: Health professional consultant v Johnson & Johnson – Online Nicorette advertisement (No breach)

Complaint about a Nicorette online ad: use of an infant image and a β€œ43% more effective” claim without…

8 Mar 2026

AUTH/2053/10/07: GlaxoSmithKline v AstraZeneca – Symbicort SMART leavepiece (no breach)

GSK challenged an AstraZeneca Symbicort SMART leavepiece for an unqualified β€˜Rx… plus as needed’ dosing line. The Panel…

8 Mar 2026

ProStrakan press release on Rectogesic: β€˜aiding healing’ claim ruled inaccurate (Clauses 9.1, 20.2); no promotion breach

A public complaint challenged a Rectogesic press release implying it aided fissure healing. PMCPA ruled the statement inaccurate…

8 Mar 2026

Anonymous v Merck Sharp & Dohme: Cerazette Discount Scheme (AUTH/2613/6/13)

PMCPA case AUTH/2613/6/13 about a Cerazette discount scheme. The matter was found to be outwith the scope of…

8 Mar 2026

GSK voluntary admission: out-of-date prescribing information used in Avandamet ads (AUTH/1922/11/06)

GSK disclosed that Avandamet ads ran for ~3 months with outdated prescribing information omitting macular oedema as a…

8 Mar 2026

Biogen Idec: Imraldi aRMMs sent by recorded delivery to a doctor’s home address (AUTH/3121/11/18)

A hospital doctor said an Imraldi mailing requiring a signature was harassment and an inappropriate marketing practice. Panel…

8 Mar 2026

Strides Pharma: LinkedIn comment promoted POM Strivit D3 to the public (AUTH/3347/5/20)

A senior employee’s LinkedIn comment praising Strivit D3 (β€œlicensed, prescribed, kosher and halal”) was ruled to be public…

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training